Patent details

EP2101733 Title: POWDER FORMULATION FOR VALGANCICLOVIR

Basic Information

Publication number:
EP2101733
PCT Application Number:
PCT/EP/2007/063151
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP078476629
PCT Publication Number:
WO/2008/071573
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
POWDER FORMULATION FOR VALGANCICLOVIR
French Title of Invention:
PRÉPARATION EN POUDRE DU VALGANCICLOVIR
German Title of Invention:
PULVERFORMULIERUNG FÜR VALGANCICLOVIR
SPC Number:

Dates

Filing date:
03/12/2007
Grant date:
26/09/2012
EP Publication Date:
26/09/2012
PCT Publication Date:
19/06/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/09/2009
EP B1 Publication Date:
26/09/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/12/2017
Expiration date:
03/12/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/12/2007
 
 

Name:
F. Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/10/2012
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
INFELD Martin Howard
Address:
United States (US)

2

Name:
BACHYNSKY Maria Oksana
Address:
United States (US)

3

Name:
SHAH Navnit Hargovindas
Address:
United States (US)

Priority

Priority Number:
874634 P
Priority Date:
13/12/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/14;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
16/12/2016
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages